Nicholas DiGioia Alexion/Astrazeneca Rare Disease
Nicholas DiGioia Alexion/Astrazeneca Rare Disease Associate Director, CMC Leadership
Nicholas holds a degree in chemical engineering from the University of Massachusetts at Amherst and has over 7 years of experience in the biotech industry developing biologics manufacturing processes. He got his start supporting commercial manufacturing at Sanofi and has since held roles of increasing responsibility in the process development groups at Bristol Meyers Squibb and LogicBio therapeutics. He is currently serving as an associate director of genomic medicines CMC leadership at Alexion pharmaceuticals.